The Mackenzie Evangelical University Hospital is the Mackenzie Evangelical College of Paraná's university hospital, located in Curitiba, State of Paraná, Brazil.

There are 475 beds in Hospital Universitário Evangélico de Curitiba.

During the past decade, Hospital Universitário Evangélico de Curitiba conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitário Evangélico de Curitiba" are "Atrial Fibrillation" (1 trials), "Cellulitis" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Hospital Universitário Evangélico de Curitiba" in a lesser frequency.

Most popular intervention types in "Hospital Universitário Evangélico de Curitiba" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Daptomycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitário Evangélico de Curitiba" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitário Evangélico de Curitiba". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Universitário Evangélico de Curitiba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitário Evangélico de Curitiba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".